Intralipid infusion therapy as an adjunct treatment in women experiencing adenomyosis-related infertility.
- Published in:
- Therapeutic Advances in Reproductive Health, 2023, v. 17, p. 1, doi. 10.1177/26334941231181258
- By:
- Publication type:
- Article
Works matching IS 26334941 AND DT 2023 AND VI 17
Results: 9
1
2
Treatment modalities for poor ovarian responders.
- Published in:
- Therapeutic Advances in Reproductive Health, 2023, v. 17, p. 1, doi. 10.1177/26334941221147464
- By:
- Publication type:
- Article
3
Neurokinin receptor antagonists as potential non-hormonal treatments for vasomotor symptoms of menopause.
- Published in:
- Therapeutic Advances in Reproductive Health, 2023, v. 17, p. 1, doi. 10.1177/26334941231177611
- By:
- Publication type:
- Article
4
Advances in contraception: vaginal contraceptive rings.
- Published in:
- Therapeutic Advances in Reproductive Health, 2023, v. 17, p. 1, doi. 10.1177/26334941231186733
- By:
- Publication type:
- Article
5
Effects of sperm processing techniques on IVF pregnancy rates: a mini-review.
- Published in:
- Therapeutic Advances in Reproductive Health, 2023, v. 17, p. 1, doi. 10.1177/26334941231188656
- By:
- Publication type:
- Article
6
Refusal of the hospitalization: a distressed dilemma in obstetric practice.
- Published in:
- Therapeutic Advances in Reproductive Health, 2023, v. 17, p. 1, doi. 10.1177/26334941231216531
- By:
- Publication type:
- Article
7
Emerging concepts in male contraception: a narrative review of novel, hormonal and non-hormonal options.
- Published in:
- Therapeutic Advances in Reproductive Health, 2023, v. 17, p. 1, doi. 10.1177/26334941221138323
- By:
- Publication type:
- Article
8
Reversible interventions for menstrual management in adolescents and young adults with gender incongruence.
- Published in:
- Therapeutic Advances in Reproductive Health, 2023, v. 17, p. 1, doi. 10.1177/26334941231158251
- By:
- Publication type:
- Article
9
Risk of ovarian hyperstimulation syndrome in women with malignancies undergoing treatment with long-acting gonadotropin-releasing hormone agonist after controlled ovarian hyperstimulation for fertility preservation: a systematic review.
- Published in:
- Therapeutic Advances in Reproductive Health, 2023, v. 17, p. 1, doi. 10.1177/26334941231196545
- By:
- Publication type:
- Article